SERUM LEVELS OF INTERFERON-GAMMA INDUCIBLE PROTEIN (IP-)10 ARE ASSOCIATED WITH RESPONSE TO PEGINTERFERON TREATMENT IN GENOTYPE D HBEAG-NEGATIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Arends, Pauline [1 ]
Sonneveld, Milan J. [1 ]
Hansen, Bettina E. [1 ]
Groothuismink, Zwier M. [1 ]
Boonstra, Andre [1 ]
Janssen, Harry L. [1 ]
机构：
[1] Erasmus MC Univ Hosp, Rotterdam, Netherlands
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1019A / 1019A
页数：1
相关论文
共 50 条
  • [1] High Pre-Treatment Serum Interferon-Gamma-Inducible Protein 10 (IP-10) Levels Is Associated With HBsAg Seroconversion After Peginterferon Therapy in HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B
    Poovorawan, Kittiyod
    Tangkijvanich, Pisit
    Chirathaworn, Chintana
    Poovorawan, Yong
    Chaiteerakij, Roongruedee
    Komolmit, Piyawat
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S960 - S960
  • [2] Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B
    Sonneveld, Milan J.
    Arends, Pauline
    Boonstra, Andre
    Hansen, Bettina E.
    Janssen, Harry L. A.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 898 - 903
  • [3] Association of interferon-gamma inducible protein 10 polymorphism with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B
    Limothai, Umaporn
    Chuaypen, Natthaya
    Khlaiphuengsin, Apichaya
    Posuwan, Nawarat
    Wasitthankasem, Rujipat
    Poovorawan, Yong
    Tangkijvanich, Pisit
    [J]. ANTIVIRAL THERAPY, 2016, 21 (02) : 97 - 106
  • [4] Association of Interferon-gamma Inducible Protein 10 Polymorphism with Treatment Response to Pegylated Interferon in HBeAg-Positive Chronic Hepatitis B
    Tangkijvanich, Pisit
    Limothai, Umaporn
    Chuaypen, Natthaya
    Khlaiphuengsin, Apichaya
    Wasitthankasem, Rujipat
    Poovorawan, Yong
    [J]. HEPATOLOGY, 2015, 62 : 1201A - 1201A
  • [5] Association of pretreatment serum interferon-gamma inducible protein 10 (IP-10) levels with virological response to lamivudine monotherapy and lamivudine interferon sequential treatment in chronic hepatitis B
    Nagaoka, Shinya
    Yatsuhashi, Hiroshi
    Nakao, Rumiko
    Fukuda, Mika
    Hashimoto, Satoru
    Nishikawa, Akiko
    Hai, Naruhiro
    Tateyama, Masakuni
    Ozawa, Eisuke
    Taura, Naota
    Abiru, Seigo
    Yano, Koji
    Komori, Atsumasa
    Migita, Kiyoshi
    Fujioka, Hikaru
    Ishibashi, Hiromi
    [J]. HEPATOLOGY, 2007, 46 (04) : 670A - 671A
  • [6] Retherapy with lamivudine in HBeAg-negative chronic hepatitis B patients unresponsive to interferon/peginterferon treatment
    Fedorchenko, S. V.
    Martynovich, T. L.
    Yanchenko, V. I.
    Klimenko, Zh. B.
    Lyashok, O. V.
    [J]. VOPROSY VIRUSOLOGII, 2011, 56 (03) : 37 - 40
  • [7] Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon
    Brunetto, MR
    Oliveri, F
    Colombatto, P
    Coco, B
    Ciccorossi, P
    Bonino, F
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 : S164 - S167
  • [8] Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon
    Lampertico, Pietro
    Vigano, Mauro
    Colombo, Massimo
    [J]. LIVER INTERNATIONAL, 2011, 31 : 90 - 94
  • [9] INTERFERON-GAMMA-INDUCIBLE PROTEIN 10 PROMOTER POLYMORPHISM RELATED WITH END-OF-TREATMENT HBsAg LEVELS AND HAD COMPLEMENTARY ROLE IN PREDICTION OF SUSTAINED VIROLOGIC RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B: MULTICENTER STUDY
    Thanapirom, K.
    Suksawatamnuay, S.
    Sukeepaisarnjareon, W.
    Tanwandee, T.
    Thongsawat, S.
    Leerapun, A.
    Piratvisuth, T.
    Boonsirichan, R.
    Bunchorntavakul, C.
    Pattanasirigool, C.
    Pornthisarn, B.
    Tantipanichtheerakul, S.
    Sripariwuth, E.
    Jeamsripong, W.
    Sanpajit, T.
    Poovorawan, Y.
    Komolmit, P.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S546 - S547
  • [10] Interferon-inducible protein 10 (IP10) serum levels predict the decline of HBsAg serum levels in HBeAg-negative chronic hepatitis B (CHBe-) patients treated with tenofovir disoproxil fumarate (TDF)
    Papatheodoridis, George V.
    Triantos, Christos K.
    Hadziyannis, Emilia
    Zisimopoulos, Konstantinos
    Georgiou, Anastasia
    Voulgaris, Theodoros
    Vlachogiannakos, Jiannis
    Nikolopoulou, Vasiliki
    Manolakopoulos, Spilios
    [J]. HEPATOLOGY, 2014, 60 : 1110A - 1110A
12345